Discovery of new natural products from Actinobacteria using Cas12a-directed cloning
This research demonstrates the efficacy of a genome-led approach to drug discovery, which has successfully translated genomic data into tangible chemical matter, functionally characterised previously cryptic BGCs, and contributed a novel class of antibiotics to the global pipeline for combating infectious diseases.